Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis (CLLS) has released its monthly share capital and voting rights report as of May 31, 2025. The company reported a total of 100,325,229 shares in its capital structure, with 89,110,384 total voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority. The company maintains its listing on Euronext Growth under the ISIN code FR0010425595.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, June 05, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
05/31/2025	100,325,229	89,110,384

For further information on Cellectis, please contact:     

Media contacts:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:       

Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com 

Attachment

• Voting_Rights_PR_May_2025_EN

FAQ

What is the current total number of shares in Cellectis (CLLS) as of May 2025?

As of May 31, 2025, Cellectis has 100,325,229 total shares in its capital structure.

How many voting rights does Cellectis (CLLS) have as of May 2025?

Cellectis reported 89,110,384 total voting rights as of May 31, 2025.

Where is Cellectis (CLLS) stock listed?

Cellectis is listed on Euronext Growth under the ISIN code FR0010425595.

What is the difference between Cellectis total shares and voting rights in May 2025?

There is a difference of 11,214,845 between the total number of shares (100,325,229) and voting rights (89,110,384).